NDC11 59390014005
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 59390-0140-05 | 59390-0140 |
| 59390-0140-5 | 59390-0140 |
| 59390-140-05 | 59390-140 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ofloxacin ophthalmic | OFLOXACIN | Altaire Pharmaceuticals Inc. | fe564e33-8f5d-4b57-87a9-7afae02eaf97 | 2022-10-28 | Warnings, Adverse reactions | 59390-140-05 59390-140 59390014005 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.